| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/07/2001 | EP1079843A2 USE OF g(a)1 g(b) INTEGRIN RECEPTOR INHIBITORS AND TGF- g(b)1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE |
| 03/07/2001 | EP1079813A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/07/2001 | EP0587636B1 Fish vaccine for aeromonas salmonicida infection |
| 03/07/2001 | CN1286727A Neisserial antigens |
| 03/07/2001 | CN1286726A Histamine and serotonin binding molecules |
| 03/07/2001 | CN1286698A Human angiotonin II/vasopressin receptor like gene |
| 03/07/2001 | CN1286696A Liposomes comprising peptide antigens derived from X protein of hepatitis B virus |
| 03/07/2001 | CN1286120A Cholera vaccine prepared from transgenic carrot and its preparing process |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/07/2001 | CN1062770C Vaccine both for hepatitis A and measles, and production method therefor |
| 03/06/2001 | US6197939 Polypeptide regulator; for use as a diagnostic tool in detection of tumors |
| 03/06/2001 | US6197931 Human marco scavenger receptor |
| 03/06/2001 | US6197930 Polypeptide for use in organ preservation, cryopreservation, for surgical pretreatment to prevent injury due to inflammation; antiischemic agents |
| 03/06/2001 | US6197929 Bacterial polypeptide for use in prevention of bacterial infection |
| 03/06/2001 | US6197755 Compositions and methods for delivery of genetic material |
| 03/06/2001 | US6197583 Therapeutic compounds |
| 03/06/2001 | US6197582 Development of human monoclonal antibodies and uses thereof |
| 03/06/2001 | US6197546 PcrA Helicase of Staphylococcus aureus |
| 03/06/2001 | US6197541 Nucleic acid which codes for mammalian receptor having seven transmembrane domains; drug screening of anticoagulants and wound healing agents; diagnosis of cardiovascular disorders; treatment of restenosis and unstable angina |
| 03/06/2001 | US6197533 Minimizing interference in immunoassay of serum sample by chemically modifying arginine, histidine, lysine, threonine, or tyrosine located in active site of antibody, antigen, or fragment |
| 03/06/2001 | US6197528 Composition of immunotoxins and retinoids and use thereof |
| 03/06/2001 | US6197524 Methods for detecting, identifying, isolating, and selectively labelling and targeting TH1 lymphocyte by means of the LAG-3 protein |
| 03/06/2001 | US6197511 Amino acid sequence; diagosis and treatment of cancer and skin disorders; anticarcinogenic agents; recombinant production; hybridization probes |
| 03/06/2001 | US6197497 Immunoassay for herpes simplex virus |
| 03/06/2001 | US6197496 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80 |
| 03/06/2001 | US6197312 Surface antigen |
| 03/06/2001 | US6197311 Induction of cytotoxic T-lymphocyte responses |
| 03/06/2001 | US6197310 Causative agent of the mystery swine disease, vaccine compositions and diagnostics kits |
| 03/06/2001 | US6197301 Compositions and methods for the prevention and diagnosis of Lyme disease |
| 03/06/2001 | US6197300 ftsZ |
| 03/06/2001 | US6197299 Target cell is contacted with a target cell lysis effective amount of a soluble monoclonal antibody or fragment conjugate covalently linked by peptide bond linkage to a superantigen for the lysis of a target cell by assistance of lymphocytes |
| 03/06/2001 | US6197298 Administering a molecular conjugate having a polymer backbone or microbead coupled with a plurality of binding molecules which lack an fc portion, each being specific for an antigen on a t cell; used to increase activation of t cells |
| 03/06/2001 | US6197297 Monoclonal antibody specific to polypeptide which induces interferon-gamma production |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/06/2001 | CA1341199C Method for obtaining a vaccine with wide protective range against group b neisseria meningitidis, the resulting vaccine, gammaglobulin and transfer factor |
| 03/06/2001 | CA1341198C Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor |
| 03/01/2001 | WO2001014884A1 Melanoma associated antigen (hmw-maa) defined by a monoclonal antibody |
| 03/01/2001 | WO2001014881A1 Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-ms immune response |
| 03/01/2001 | WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | WO2001014556A1 Novel b7-4 molecules and uses therefor |
| 03/01/2001 | WO2001014554A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | WO2001014549A1 Gas1 polypeptides |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014545A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 03/01/2001 | WO2001014535A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 03/01/2001 | WO2001014528A1 Method of preparing immune response-inducing dendritic cells |
| 03/01/2001 | WO2001014424A2 Human ctla-4 antibodies and their uses |
| 03/01/2001 | WO2001014421A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 03/01/2001 | WO2001014416A2 Synthetic papillomavirus genes optimized for expression in human cells |
| 03/01/2001 | WO2001014415A2 Egfh2 genes and gene products |
| 03/01/2001 | WO2001014411A1 Recombinant subunit vaccine |
| 03/01/2001 | WO2001014408A2 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 03/01/2001 | WO2001014395A2 Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 03/01/2001 | WO2001013948A1 Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis |
| 03/01/2001 | WO2001013946A2 Method for isolating and purifying grass pollen allergens |
| 03/01/2001 | WO2001013945A1 Methods and compositions for immunotherapy of b cell involvement in promotion of a disease condition comprising multiple sclerosis |
| 03/01/2001 | WO2001013944A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 03/01/2001 | WO2001013943A2 Stress protein-peptide complexes as vaccines against intra cellular pathogens |
| 03/01/2001 | WO2001013942A2 Trehalose producing prokaryotic cells as vaccines |
| 03/01/2001 | WO2001013941A1 Method for destroying, weakening and modifying micro-organisms, using high pressure |
| 03/01/2001 | WO2001013940A1 Hm1.24 antigen expression potentiators |
| 03/01/2001 | WO2001013934A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 03/01/2001 | WO2001013923A1 Malaria gpi anchors as vaccines anti-parasitic drugs and for use in diagnostics |
| 03/01/2001 | WO2001013898A2 Pharmaceutical formulations with different release times |
| 03/01/2001 | WO2001013896A1 A vaccine composition and method of using the same |
| 03/01/2001 | WO2001013714A2 Prostatic cell line and animal model of a prostatic tumor |
| 03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
| 03/01/2001 | WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3) |
| 03/01/2001 | WO2000073415A3 A method for the transfer of antigens to dendritic cells |
| 03/01/2001 | WO2000065060A3 Dna sequence and recombinant production of a graminae allergen |
| 03/01/2001 | WO2000056361A3 Vaccine composition |
| 03/01/2001 | WO2000049038A3 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 03/01/2001 | WO2000048638A3 Multi-mutant diphtheria toxin vaccines |
| 03/01/2001 | WO2000029582A8 Cell surface receptor antigen vaccines |
| 03/01/2001 | WO2000029434A3 PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
| 03/01/2001 | DE19939982A1 Verfahren zur Isolierung und Aufreinigung von Gräserpollenallergenen A process for the isolation and purification of grass pollen allergens |
| 03/01/2001 | CA2589418A1 Human ctla-4 antibodies and their uses |
| 03/01/2001 | CA2383456A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | CA2382795A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 03/01/2001 | CA2382674A1 Gas1 polypeptides |
| 03/01/2001 | CA2382652A1 A vaccine composition and method of using the same |
| 03/01/2001 | CA2382587A1 Hm1.24 antigen expression potentiators |
| 03/01/2001 | CA2382221A1 Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis |
| 03/01/2001 | CA2382204A1 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal |
| 03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | CA2382176A1 Recombinant subunit vaccine |
| 03/01/2001 | CA2382174A1 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 03/01/2001 | CA2382146A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | CA2381991A1 Synthetic human papillomavirus genes |
| 03/01/2001 | CA2381340A1 Method for isolating and purifying grass pollen allergens |
| 03/01/2001 | CA2381099A1 Melanoma associated antigen (hmw-maa) defined by a monoclonal antibody |
| 03/01/2001 | CA2380333A1 Pharmaceutical formulations |
| 03/01/2001 | CA2376406A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | CA2376250A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 02/28/2001 | EP1078992A2 Polyclonal and Monoclonal Oligobodies (Synthetic, Oligonucleotide-Based Antibody-Like Reagents), and a method of producing oligobodies |
| 02/28/2001 | EP1078988A1 Pseudomonas fusion protein vaccines |